ABO Blood Group and Risk of Venous Thrombosis in Heterozygous Carriers of Factor V Leiden

A. Robert; M. F. Aillaud; V. Eschwège; A. Randrianjohany; Y. Scarabin; I. Juhan-Vague

doi:10.1055/s-0037-1613876

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2000; 83(04): 630-631
DOI: 10.1055/s-0037-1613876

Letters to the Editor

Schattauer GmbH

ABO Blood Group and Risk of Venous Thrombosis in Heterozygous Carriers of Factor V Leiden

A. Robert

¹From Laboratoire d’Hématologie, Hôpital Saint-Antoine, Assistance Publique-Hôpitaux de Paris, Paris

,

M. F. Aillaud

²Laboratoire d’Hématologie, CHU La Timone, Marseille, France

,

V. Eschwège

¹From Laboratoire d’Hématologie, Hôpital Saint-Antoine, Assistance Publique-Hôpitaux de Paris, Paris

,

A. Randrianjohany

³Service des Maladies Infectieuses, Hôpital Avicenne, Bobigny, France

,

Y. Scarabin

⁴INSERM U258, Hôpital Broussais, Paris, France

,

I. Juhan-Vague

²Laboratoire d’Hématologie, CHU La Timone, Marseille, France

› Author Affiliations

Abstract

Full Text

References

References
1 Rosendaal FR. Venous thrombosis: a multicausal disease. Lancet 1999; 353: 1167-73.
2 Tosetto A, Rodeghiero F, Martinelli I, De Stefano V, Missiaglia E, Chiusolo P, Manucci PM. Additional genetic risk factors for venous thromboembolism in carriers of the factor V Leiden mutation. Brit J Haematol 1998; 103: 871-6.
3 Jick H, Westerholm B, Vessey MP, Lewis GP, Slone D, Inman WHW, Shapiro S, Worcester J. Venous thromboembolic disease and ABO blood group type. A cooperative study. Lancet 1969; 01: 539-42.
4 Talbot S, Ryrie D, Wakley EJ, Langman MJS. ABO blood-group and venous thromboembolic disease. Lancet 1970; 01: 1257-9.
5 Koster T, Blann AD, Briët E, Vandenbroocke JP, Rosendaal FR. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 1995; 345.
6 Wautrecht JC, Galle C, Motte S, Dereume JP, Dramaix M. The role of ABO blood groups in the incidence of deep vein thrombosis. Thromb Haemost 1998; 79: 689-90.
7 Gonzales AJOrdonez, Medina Rodriguez JM, Martin L, Alvarez V, Coto E. The O blood group protects against venous thromboembolism in individuals with the factor V Leiden but not the prothrombin (factor II G20210A) mutation. Blood Coag Fibrinolysis 1999; 10: 303-307.
8 Gill JC, Endres-Brooks J, Bauer PJ, Marks Jr WJ, Montgomery RR. The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood 1987; 69: 1691-5.
9 McLellan DS, Knight SR, Aronstam A. The relationship between coagulation factor VIII and ABO blood group status. Med Lab Sci 1988; 45: 131-4.